α-galacto-oligosaccharides dose-dependently reduce appetite and decrease inflammation in overweight adults

Journal of Nutrition

Volumn 145, Issue 9, 2015, Pages 2052-2059

  Morel, Fanny B ^a   Dai, Qiuping ^b   Ni, Jiayi ^a,c   Thomas, Doneal ^c   Parnet, Patricia ^d   Fança Berthon, Pascale ^a  

^a Olygose SAS ^*  (China)

^b TONGJI UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

Alph galacto oligosaccharides; Appetite; Fibers; Food intake; Inflammation

Indexed keywords

ALPHA GALACTO OLIGOSACCHARIDE; C REACTIVE PROTEIN; GALACTOSE OLIGOSACCHARIDE; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; 4'-GALACTOOLIGOSACCHARIDE; TRISACCHARIDE;

ADULT; APPETITE; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; DECREASED APPETITE; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HUMAN; INFLAMMATION; INTESTINE FLORA; LEGUME; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SATIETY; STOMACH EMPTYING; TEA; TEST MEAL; VISUAL ANALOG SCALE; ADOLESCENT; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECTS; MEAL; MIDDLE AGED; OVERWEIGHT; TREATMENT OUTCOME; WEIGHT REDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; APPETITE; BODY MASS INDEX; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; HUMANS; INFLAMMATION; MALE; MEALS; MIDDLE AGED; OVERWEIGHT; SATIATION; TREATMENT OUTCOME; TRISACCHARIDES; WEIGHT LOSS; YOUNG ADULT;

EID: 84941035504     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.204909     Document Type: Article

References (32)

1. WHO. Fact sheet No. 311 [updated 2015 Jan; cited 2015 Jun 8]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640-5.
3. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev 2001;59:129-39.
4. Blundell JE, Burley VJ. Satiation, satiety and the action of fibre on food intake. Int J Obes 1987;11 Suppl 1:9-25.
5. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90(5):1236-43.
6. Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009;89(6):1751-9.
7. Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, Frost GS. Gut hormone release and appetite regulation in healthy nonobese participants following oligofructose intake: a dose-escalation study. Appetite 2013;66:44-53.
8. Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 2006;60(5):567-72.
9. Harrold JA, Hughes GM, O'Shiel K, Quinn E, Boyland EJ, Williams NJ, Halford JC. Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choice. Appetite 2013;62:84-90.
10. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58 (8):1091-103.
11. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012;61:364-71.
12. Zhou J, Hegsted M, McCutcheon KL, Keenan MJ, Xi X, Raggio AM, Martin RJ. Peptide YYand proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring) 2006;14:683-9.
13. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011;7:639-46.
14. Hernandez-Hernandez O, Cote GL, Kolida S, Rastall RA, Sanz ML. In vitro fermentation of alternansucrase raffinose-derived oligosaccharides by human gut bacteria. J Agric Food Chem 2011;59:10901-6.
15. Rycroft CE, Jones MR, Gibson GR, Rastall RA. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 2001;91:878-87.
16. Gulewicz P, Szymaniec S, Bubak B, Frias J, Vidal-Valverde C, Trojanowska K, Gulewicz K. Biological activity of alpha-galactoside preparations from Lupinus angustifolius L. and Pisum sativum L. seeds. J Agric Food Chem 2002;50:384-9.
17. Bang MH, Chio OS, Kim WK. Soyoligosaccharide increases fecal bifidobacteria counts, short-chain fatty acids, and fecal lipid concentrations in young Korean women. J Med Food 2007;10:366-70.
18. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, Brouns F, Bornet FR. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 2004;80(6):1658-64.
19. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. Effects of soybean oligosaccharides on human faecal flora. Microb Ecol Health Dis 1990;3:293-303.
20. Verhoef SP, Meyer D, Westerterp KR. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 2011;106:1757-62.
21. Kaplan H, Hutkins RW. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Appl Environ Microbiol 2000;66:2682-4.
22. Suzuki N, Aiba Y, Takeda H, Fukumori Y, Koga Y. Superiority of 1-kestose, the smallest fructo-oligosaccharide, to a synthetic mixture of fructo-oligosaccharides in the selective stimulating activity on bifidobacteria. Biosci Microflora 2006;25:109-16.
23. Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 2001;86:291-300.
24. Kruger MC, Brown KE, Collett G, Layton L, Schollum LM. The effect of fructooligosaccharides with various degrees of polymerization on calcium bioavailability in the growing rat. Exp Biol Med (Maywood) 2003;228:683-8.
25. Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997;18:1371-4.
26. Fança-Berthon P, Hoebler C, Mouzet E, David A, Michel C. Intrauterine growth restriction not only modifies the cecocolonic microbiota in neonatal rats but also affects its activity in young adult rats. J Pediatr Gastroenterol Nutr 2010;51:402-13.
27. Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev 2010;11(3):251-70.
28. Hetherington MM, Cunningham K, Dye L, Gibson EL, Gregersen NT, Halford JC, Lawton CL, Lluch A, Mela DJ, Van Trijp HC. Potential benefits of satiety to the consumer: scientific considerations. Nutr Res Rev 2013;26:22-38.
29. Dehghan P, Pourghassem Gargari B, Asghari Jafar-abadi M. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial. Nutrition 2014;30:418-23.
30. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of transgalactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 2013;143:324-31.
31. Trussardi Fayh AP, Lopes AL, Fernandes PR, Reischak-Oliveira A, Friedman R. Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial. Br J Nutr 2013;110:486-92.
32. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemiainduced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.